Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pedro Lichtinger currently holds 74,833 shares of Gemphire Therapeutics Inc. (GEMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pedro Lichtinger has been a net seller of GEMP stock. They have purchased $1.0M and sold $2.2M worth of shares.
Pedro Lichtinger's most recent insider trade was on Jul 24, 2019, when they sold 15,000 shares at $0.00 per share.
Pedro Lichtinger serves as Executive at Gemphire Therapeutics Inc. (GEMP). They have executed 23 insider transactions totaling $3.2M over their tenure at the company.
Pedro Lichtinger holds the position of Executive at Gemphire Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Pedro Lichtinger has shown a selling trading pattern, with $1.0M in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pedro Lichtinger was on Apr 8, 2013, when they sold $1.3M worth of OPTR shares. This transaction involved 90,000 shares at $14.73 per share.
Pedro Lichtinger currently owns 74,833 shares of Gemphire Therapeutics Inc. (GEMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pedro Lichtinger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pedro Lichtinger has 23 Form 4 filings on record as an insider at Gemphire Therapeutics Inc..
Set alerts for Pedro Lichtinger and 40,000+ other insiders.